- Public Comps
- Biora Therapeutics
Biora Therapeutics Valuation Multiples
Discover revenue and EBITDA valuation multiples for Biora Therapeutics and similar public comparables like Odyssey Health, Brain Scientific, Bluejay Diagnostics, Inhalation Sciences SWE and more.
Biora Therapeutics Overview
About Biora Therapeutics
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
Founded
2012
HQ

Employees
6
Website
Financials (FY)
EV
$37M
Valuation Multiples
Start free trialBiora Therapeutics Stock Performance
Biora Therapeutics has current market cap of $995K, and enterprise value of $37M.
Biora Therapeutics' stock price is $0.22.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $37M | $995K | 0.0% | - | - | - | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBiora Therapeutics Valuation Multiples
Biora Therapeutics Financial Valuation Multiples
As of August 14, 2026, Biora Therapeutics has market cap of $995K and EV of $37M.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Biora Therapeutics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Biora Therapeutics Competitors
Biora Therapeutics competitors include Odyssey Health, Brain Scientific, Bluejay Diagnostics, Inhalation Sciences SWE, Epigenomics, Sunniva, Bone Biologics, Luxbright, Integragen and EvokAI.
Most Biora Therapeutics public comparables operate across Diagnostics & Genomics, Medical Devices, BioTech and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | (2.2x) | - | |||
| 14.2x | - | (0.4x) | - | |||
| - | - | 0.4x | - | |||
| 1.6x | - | (0.5x) | - | |||
| 499.8x | - | (38.2x) | - | |||
| - | - | - | - | |||
| - | - | 1.0x | - | |||
| 0.8x | 0.8x | (0.6x) | (0.5x) | |||
This data is available for Pro users. Sign up to see all Biora Therapeutics competitors and their valuation data. Start Free Trial | ||||||
Biora Therapeutics VC Funding History
Before going public, Biora Therapeutics raised $139M in total equity funding, across 2 rounds.
Biora Therapeutics Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Biora Therapeutics
| When was Biora Therapeutics founded? | Biora Therapeutics was founded in 2012. |
| Where is Biora Therapeutics headquartered? | Biora Therapeutics is headquartered in United States. |
| How many employees does Biora Therapeutics have? | As of today, Biora Therapeutics has over 6 employees. |
| Is Biora Therapeutics publicly listed? | Yes, Biora Therapeutics is a public company listed on Berlin Stock Exchange. |
| What is the stock symbol of Biora Therapeutics? | Biora Therapeutics trades under 4ZU ticker. |
| When did Biora Therapeutics go public? | Biora Therapeutics went public in 2020. |
| Who are competitors of Biora Therapeutics? | Biora Therapeutics main competitors include Odyssey Health, Brain Scientific, Bluejay Diagnostics, Inhalation Sciences SWE, Epigenomics, Sunniva, Bone Biologics, Luxbright, Integragen, EvokAI. |
| What is the current market cap of Biora Therapeutics? | Biora Therapeutics' current market cap is $995K. |
| Is Biora Therapeutics profitable? | No, Biora Therapeutics is not profitable. |
| How many companies Biora Therapeutics has acquired to date? | Biora Therapeutics hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Biora Therapeutics has invested to date? | Biora Therapeutics hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Biora Therapeutics
Lists including Biora Therapeutics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




